Ocular myasthenia gravis
- 1 December 1993
- journal article
- review article
- Published by Springer Science and Business Media LLC in Documenta Ophthalmologica
- Vol. 84 (4), 309-333
- https://doi.org/10.1007/bf01215447
Abstract
Myasthenia gravis (MG) is probably the best studied autoimmune disease caused by autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction, subsequently leading to abnormal fatigability and weakness of skeletal muscle. Extraocular muscle weakness with droopy eyelids and double vision is present in about 90% of MG patients, being the initial complaint in about 50%. In approximately 20% of the patients the disease will always be confined to the extraocular muscles. The single most important diagnostic test is the detection of serum antibodies against AChR which is positive in 90% of patients with generalized MG, but only in 65% with purely ocular MG. Electromyographic studies and the Tensilon test are of diagnostic value in clear-cut cases, but may be equivocal in purely ocular myasthenia, especially the latter not rarely producing false-positive results. Treatment response to corticosteroids and anti-cholinesterase agents is satisfactory in many patients with ocular MG, however other immunosuppressive drugs may also be needed. Pathogenetically relevant steps of the underlying autoimmune process have been elucidated during the last few years; nevertheless a number of questions remain open, especially what starts off the autoimmune process, and why are eye muscles so frequently involved in MG?Keywords
This publication has 123 references indexed in Scilit:
- T-cell reactivity in myasthenia gravisJournal of Autoimmunity, 1989
- The effect of cholinesterase inhibitors on SFEMG in myasthenia gravisMuscle & Nerve, 1989
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Vertical DiplopiaSeminars in Neurology, 1986
- Serumspiegel von Pyridostigmin bei Myasthenia gravis: Methoden und klinische BedeutungFortschritte der Neurologie · Psychiatrie, 1985
- Neurologische Indikation zur PlasmaphereseAktuelle Neurologie, 1984
- The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipientsClinical Immunology and Immunopathology, 1981
- Disorders of Neuromuscular Transmission Caused by DrugsNew England Journal of Medicine, 1979
- Myasthenia GravisNew England Journal of Medicine, 1977
- MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGIONAnnals of Surgery, 1939